|

Glycemic Variability of Combination Therapies in T2DM

RECRUITINGPhase 4Sponsored by JW Pharmaceutical
Actively Recruiting
PhasePhase 4
SponsorJW Pharmaceutical
Started2025-10-29
Est. completion2027-03-31
Eligibility
Age19 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07442006

Summary

Glycemic Variability of Combination Therapies in T2DM

Eligibility

Age: 19 Years+Healthy volunteers accepted
Inclusion Criteria:

* Inadequate glycemic control despite treatment with Metformin (≥ 1,000mg/day) and SGLT-2 inhibitor.

Exclusion Criteria:

* History of acute or chronic metabolic acidosis
* Moderate to severe renal impairment (eGFR \< 45 mL/min/1.73m²)
* Severe hepatic impairment
* History of heart failure (NYHA Class III/IV)

Conditions2

DiabetesType 2 Diabetes Mellitus (T2DM)

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.